Jci_page_head_homepage_01 Jci_page_head_homepage_02
Caroline Cheng, Dennie Tempel, Rien van Haperen, Hetty C. de Boer, Dolf Segers, Martin Huisman, Anton Jan van Zonneveld, Pieter J.M. Leenen, Anton van der Steen, Patrick W. Serruys, Rini de Crom, Rob Krams
Published in Volume 117, Issue 3
J Clin Invest. 2007; 117(3):616–626 doi:10.1172/JCI28180
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Fractalkine function was inhibited during cast-induced atherogenesis in apoE–/– mice by administration of a neutralizing antibody from week 6 until week 9.

Representative cross-sections are shown stained for: lesion morphology by H&E (A), macrophages (B), lipids (C), VSMCs (D), collagen (E), and fractalkine receptor (CX3CR1) (F). Asterisks indicate the position of the lumen, while the white dotted lines demarcate the boundaries between lumen and intima. Bar diagrams represent the lesion area and quantification of the (immuno)histological analysis of the different plaque components. The percentages of positive area at 9 weeks in the intima in the LSS and the OSS regions are indicated, comparing the control antibody group (–) with the anti-fractalkine antibody group (+). n = 8. *P < 0.05 versus control antibody group.